The automotive industry has been resilient as it has dealt with supply chain disruptions, tariffs and regulatory changes for EVs over the past six years. But now automakers are entering a new phase of ...
The US auto market delivered 16.17 million vehicles in 2025, a solid year by recent standards, but what Americans actually bought tells a more complicated story. SUVs and trucks continued to dominate, ...
For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news. By submitting your ...
Health insurance companies love to save money. Who doesn’t? But the calculations for what’s cheapest don’t always look the way you’d expect. Insurers will sometimes choose to cover a significantly ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...
Please provide your email address to receive an email when new articles are posted on . Researchers captured patient and caregiver expected anxiety and well-being with different epinephrine treatment ...
DETROIT & BOSTON--(BUSINESS WIRE)--Sempresto, Inc., a medical device company pioneering smartphone integrated rescue drug delivery, today announced the acquisition of Alerje’s mobile device integrated ...
Sempresto, Inc., a medical device company pioneering smartphone integrated rescue drug delivery, today announced the acquisition of Alerje’s mobile device integrated auto-injector platform, including ...
Please provide your email address to receive an email when new articles are posted on . Feasibility and acceptability scores for the autoinjector were highest among health care professionals. All ...
MannKind Corporation delivered strong Q3 '25 results, beating EPS and revenue estimates, and shares have responded positively. The FDA accepted the supplemental New Drug Application for the FUROSCIX ...
A Prescription Drug User Fee Act target date of July 26, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the supplemental New Drug Application ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results